- MEMORANDUM OF UNDERSTANDING
- download here
for the implementation of a European Concerted Research Action
designated as
COST Action B28
“Array technologies for BLS3 and BSL4 pathogens”
designated as
COST Action B28
“Array technologies for BLS3 and BSL4 pathogens”
The Signatories to this Memorandum of Understanding, declaring their common intention to participate in the concerted Action referred to above and described in the Technical Annex to the Memorandum, have reached the following understanding:
1. The Action will be carried out in accordance with the provisions of document COST 400/01 "Rules and Procedures for Implementing COST Actions", the contents of which the Signatories are fully aware of.
2. The main objective of the Action is to increase knowledge on BLS3 and BSL4 agents in order to support the development of more accurate diagnostics, vaccines and therapeutics, and to better understand epidemiology of these highly pathogenic micro-organisms that potentially can be used as biological weapons.
3. The economic dimension of the activities carried out under the Action has been estimated, on the basis of information available during the planning of the Action, at € 22.6 Mio in 2004 prices.
4. The Memorandum of Understanding will take effect by being signed by at least [five] Signatories.
5. The Memorandum of Understanding will remain in force for a period of five years, unless the duration of the Action is modified according to the provisions of Chapter 6 of the document referred to in Point 1 above.